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Abstract
Background: Constituted only by carbon atoms, CNT are hydrophobic and hardly detectable in
biological tissues. These properties make biokinetics and toxicology studies more complex.
Methods: We propose here a method to investigate the biopersistence of CNT in organism,
based on detection of nickel, a metal present in the MWCNT we investigated.
Results and conclusion: Our results in rats that received MWCNT by intratracheal instillation,
reveal that MWCNT can be eliminated and do not significantly cross the pulmonary barrier but are
still present in lungs 6 months after a unique instillation. MWCNT structure was also showed to
be chemically modified and cleaved in the lung. These results provide the first data of CNT
biopersistence and clearance at 6 months after respiratory administration.
Background
Given the low diameter of carbon nanotube (CNT), a pos-
sible translocation of this nanomaterial from the digestive
tract to blood or from the lung to blood and then to other
organs in the body must be considered. Inhaled ultrafine
particles translocation has been previously described at
low rate in a few studies with other particles like iridium
or gold [1,2]. Up to now, direct investigations of CNT
translocation from the lung to the blood has not been
conducted. The primary reason for that is the component
structure of the CNT. Only made of carbon, CNT are diffi-
cult to distinguish from biological matrix. A few studies
have used indirect methods to investigate CNT biokinetics
(translocation, biodistribution, clearance...). Several biok-
inetics studies were performed by intra-venous injection
of functionalized-CNT. Wang et al (2004) analyzed the
biodistribution of SWCNT using a I125-SWCNT construct,
and revealed indirectly by radioactivity measurement of
I125, the presence of functionalized SWCNT in stomach,
kidneys and bone. Similar observations were obtained in
kidneys, liver and spleen by McDevitt et al (2007) with
In111-SWCNT. Functionalized SWCNT were found in the
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different organs, and biokinetics studies showed a rapid
clearance of the In111-SWCNT from blood and tissues [3-
5]. One study followed the biokinetics of injected
unmodified SWCNT using inherent near-infrared fluores-
cence of SWCNT for detection in blood and tissue samples
[6]. The authors report a rapid blood clearance and
detected SWCNT only in the liver after 24 h. These results
suggest a possible difference in biokinetics between mod-
ified and unmodified CNT. To investigate unmodified
MWCNT biokinetics, Muller et al (2005) used another
method based on the quantification of the CNT produc-
tion metal catalyst residue [7]. The production of carbon
nanotubes by arc discharge [8], laser ablation [9] and
chemical vapor deposition [10], use metal as catalysts
such as iron, nickel, cobalt, etc...which always remain as
impurities in the final product [11] and can be quantified.
Here, we have first assessed the performances of using the
metal catalyst of CNT as a tracer. We then analyzed
unmodified Nickel-catalyzed MWCNT biokinetics after
intratracheal instillation.
Results
Analysis of metal impurities
Results showed the presence of 0.53% (w/w) of Ni, 0.08%
(w/w) of S, 0.02% (w/w) of Mg, less than 0.01% (w/w) of
Na and V and less than 0.005% (w/w) each for all other
metals tested (listed in materials and methods).
Analysis of Ni-CNT bonds in the lung and in the lymph 
nods
STEM-EDX analysis of lungs and lymph nodes of
MWCNT-exposed rats showed that peaks of Ni were
observed only in the presence of MWCNT (Figure 1). The
presence of Cu is due to the TEM grid used. Ni and Mg are
impurities of MWCNT and additionally the last element is
also normal constituent of cells. Multiple sections study of
lung and lymph nodes revealed a perfect colocalization of
CNT and Ni after STEM-EDX analysis (Figure 1). Ni was
never detected in absence of CNT and vice-versa.
Biokinetics studies
Biodistribution of MWCNT
To validate our Ni dosage method, suspensions with
known final CNT quantity (0, 6.25, 12.5, 25, 50 and 100
μg) were produced in quadruplicate. The MWCNT impu-
rity study showed that Ni was present at an average con-
centration of 0.53% (w/w) of total MWCNT mass. Thus,
the theoretical final Ni quantities in the control suspen-
sions are respectively 0, 0.03, 0.06, 0.12, 0.25 and 0.5 μg.
All prepared suspensions were mineralized and measured
Ni quantities were determined by ICP-OES as it is
described in materials and methods. No statistically sig-
nificance differences between theoretical and measured
Ni quantities were observed (data not shown) suggesting
this dosage method is relevant to determine and quantify
Ni. The detection limit for this dosage was determined to
be 0.5 μg/L of Ni and correspond in our experimental con-
ditions to 100 μg/L of MWCNT.
No increases of Ni were detectable in organs after the 1 μg
or 10 μg MWCNT exposures excepted in the lung at 10 μg
of MWCNT (Figure 2). No Ni was detected at any time in
liver, kidneys, spleen, heart, brain, thymus and testis of
rats exposed to 1, 10 or 100 μg of MWCNT. Ni was
detected in the lung of MWCNT-exposed rats throughout
the experiment (from 1 to 180 days) and also detected in
lymph nodes at day 30 (Figure 2). Considering that Ni
represent 0.53% of MWCNT instilled, the percentage of
MWCNT recovered was 63% at day 1, 78% at day 7, 97%
at day 30, 38% at day 90 and 16% at day 180 (Table 1).
Ni was not detected in BALF at any time post-exposure
(Table 1).
About 50% of the instillated MWCNT were located in the
parenchyma of the lung after 1 month. 10 to 24% of CNT
were found in the alveolar cells during this period. At 30
days, 31% of total CNT injected was eliminated from the
lung but 28% of this same nanotube was found in the
lymph nods for a transition period less than 60 days.
Clearance of MWCNT was amplified at 3 and 6 months
after the exposure because 63% and 84% of total MWCNT
injected was respectively eliminated from the organism
(Table 1).
Clearance of MWCNT from the lung
To investigate the clearance mechanism, alveolar cells iso-
lated from BAL were counted with Malassez cell and
observed by optical microscopy. Significant increases in
cell number, respectively plus 44% and plus 100%, were
noted at 7 and 180 days after treatment (Figure 3). This
variation is only due to the macrophages which repre-
sented 98% of total cells, suggesting the important role of
this cell type in the bioelimination of MWCNT from the
lung. Absence of variations of other cells types were noted
(data not shown). TEM observations of the lung and the
lymph nodes sections have shown the presence of CNT
agglomerates in vacuoles (endosomes) of macrophages in
these 2 organs (Figure 4A and 4B). MWCNT were never
observed in parenchyma or other cell types than alveolar
macrophages in the lung or in the lymph nodes. To inves-
tigate the phagocytosis capacity of lung cells, total RNA
were extracted from the lung of CNT-exposed rats and spe-
cific mRNA of EEA1, an early endosome associated pro-
tein [12,13] and mRNA of β actin, a cytoskeleton protein,
were quantified by RT-PCR. Results have shown plus 50%
induction of EEA1 mRNA at day 1 and day 180 with all
doses of CNT (Figure 4C). For β actin, induction of mRNA
was significantly noted with 10 μg (plus 50% induction)
and 100 μg (plus 250% induction) of CNT at day 1 (Fig-
ure 4D). Separate quantification of macrophages contain-Particle and Fibre Toxicology 2008, 5:20 http://www.particleandfibretoxicology.com/content/5/1/20
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ing MWCNT inside their cytoplasm and macrophages
without MWCNT was performed at all times and doses.
Results showed a MWCNT dose-dependant increase of the
number of macrophages containing agglomerates of
MWCNT at all times after the exposition (Figure 5). Anal-
ysis of biopersistence of MWCNT at 1 and 10 μg, revealed
a time dependent decrease of the cells number containing
MWCNT agglomerates inside their cytoplasm. Neverthe-
less, increasing the dose of CNT induces an augmentation
of the clearance time. When the rats were treated by 100
μg of CNT, 45% of their alveolar macrophages contained
CNT agglomerates one day after the treatment. This per-
centage increased at 7 days and 1 month to 55% and 63%
respectively. Diminution of the number of phagocytosing
cells was only noted at 3 and 6 month (Figure 5). For
lower doses, the diminution of the number of phagocy-
tosing cells was noted at 7 days for 10 μg CNT and 1 days
for 1 μg CNT.
Physical and chemical modification of MWCNT in vivo
Physical modification
MWCNT were instilled in rats and after 15 days, MWCNT
lengths were compared to the control solutions by TEM.
Results showed a modification of the structure (Figure 6A,
Analysis of Ni-CNT bonds in the lung and lymph nods by STEM-EDX Figure 1
Analysis of Ni-CNT bonds in the lung and lymph nods by STEM-EDX. Rats were instilled by 2 mg of MWCNT. 
STEM-EDX analysis was performed for Ni and MWCNT detection on ultrathin sections. Spectrum of Ni analysis by EDX 
probe was performed during 60s in absence (A) or in presence (B) of MWCNT agglomerates. To observe the localization of 
Ni and MWCNT agglomerates in organism, (C) TEM photo of macrophage contains MWCNT agglomerates and (D) superpo-
sition of Ni position obtained with EDX probe (Resolution: 256 × 200; Dowell time: 800 ms; Frames: 256) in the cells were 
performed and reveal that MWCNT is colocalized with Ni.
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6B) and a significant diminution of MWCNT length sug-
gesting the capacity of rat lung to cleave MWCNT (Figure
6C).
Chemical modification
After 15 days instillation of MWCNT in rat lung, chemical
modifications of the MWCNT were assessed by infrared
spectroscopy. Presence of alcohol, carbonyl and nitrogen
function were observed on the MWCNT instillated to rat
but not on the same suspension of MWCNT that was not
injected in the presence or absence of cells residue (Figure
6D). Our results suggest the capacity of rat lung to chem-
ically modify the MWCNT structure.
Biological lung response to MWCNT
In the lung, a fraction of cells seemed to be in apoptosis
(Figure 7A) but free CNT were never found by TEM.
Results have shown no modification of mRNA level for
Elmo 3 protein (data not shown). But Elmo 1 protein
mRNA was significantly induced 1.8, 2.7 and 5.1 times
after 24 h exposure for 1, 10 and 100 μg of CNT. At day 30
and day 90, mRNA expression level was significantly
increased 2.5 times with 100 μg of CNT (Figure 7B). Sim-
Biodistribution of MWCNT in organism Figure 2
Biodistribution of MWCNT in organism. Presence of Ni was quantified in several organs. Representation of means ± SD 
of Ni quantities present in 6 rat organs from 1 to 180 days after exposure at 10 and 100 μg/rat. Results show that MWCNT 
doesn't cross lung barrier and is eliminated from the lung.
Table 1: Quantification of Ni in rat's organs after instillation of MWCNT by intratracheal instillation. 
Treatment time (days) 1 7 30 90 180
LUNG Lung after BAL 53 ± 12% 54 ± 10% 55 ± 8% 26 ± 6% 16 ± 9%
LUNG Alveolar cells 10 ± 2% 24 ± 5% 14 ± 2% 12 ± 2% -
LUNG BALF - - - - -
Lymph nodes - - 28 ± 2% - -
All other organs - - - - -
Total 63 % 78 % 97 % 38 % 16 %
- Non Detectable (< 2% of MWCNT instillated).
Groups of 6 rats were instillated by 100 μg of MWCNT and Ni was quantified by ICP-OES. Each value represents the mean ± SD of the percentage 
of Ni detected related to total Ni instillated (0.5 μg).Particle and Fibre Toxicology 2008, 5:20 http://www.particleandfibretoxicology.com/content/5/1/20
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ilar variation of mRNA level of Elmo 2 was noted because
the mRNA level was induced later 1.6, 2.7 and 3.1 times
at d1 for 1, 10 and 100 μf of CNT. At d90, mRNA expres-
sion level was only significantly increased 3.8 times with
100 μg of CNT (Figure 7C). Dock 180 mRNA was also
induced 2.5 time 1, 30 and 180 days after the exposure
(Figure 7D). Quantification of the expression of IL10 and
GM-CSF which, are also involved in the engulfment of
apoptotic cells, were performed. Inhibitions of 63% and
42% were noted for IL10 protein after 30 and 90 days
respectively (Figure 8A). Concerning GM-CSF protein, sig-
nificant inhibition was also observed 30 days after the
exposure (Figure 8B).
Discussion
Previous studies on MWCNT biodistribution were per-
formed after tracer attachment on the surface of the tubes.
But tracers modify MWCNT hydrophobicity and therefore
MWCNT biodistribution. STEM-EDX analysis of our
MWCNT reveals that Ni, which is an intrinsic impurity of
the MWCNT we used, is strongly linked to the MWCNT
and that MWCNT-Ni bonds are not affected in the body.
Our results show that Ni can be used as native MWCNT
tracer. More generally, utilization of metallic impurities as
tracers can be a good approach to assess biokinetics of
MWCNT in the body. However, the detection limit (here
0.01 μg/ml of Ni) does not allow the utilization of this
method for very low concentration of MWCNT. In addi-
tion, the strength of the bond between the metal and the
MWCNT can be different, depending on metals and CNT
types. So that STEM-EDX bonding analysis should be per-
formed for each CNT studied.
Ni quantification in several organs has revealed the pres-
ence of MWCNT only in the lungs and in the lymph
nodes. 30 days after the instillation of MWCNT, the total-
ity of particles was found in the lung (69%) and in the
lymph nodes (28%). These results suggest no, or at least a
negligible, elimination or biodistribution of CNT to other
organs 1 month after instillation. Such an observation has
already been done. In their study, Muller et al (2005) had
found no nearly elimination of MWCNT in the rat lung 28
days after an intratracheal instillation. In our experiment,
the presence of Ni in the lymph nodes was only observed
at 30 days. This result can be explained by the absence of
quantification between 7 days and 30 days and between
30 days and 90 days. Ni and so CNT is certainly not
present in the lymph nods only 30 days after exposure but
probably between more than 7 days and less than 90 days.
We have shown a decrease in the MWCNT quantity ini-
tially instilled 3 and 6 months after exposure. Three
months after, only 37% of the MWCNT remained within
the lungs and only 16% remained after 6 months. These
observations are also in accordance with the results
obtained by Muller et al, where only 18% of instilled
intact MWCNT was eliminated in the lung after 60 days
[7]. The fact that we failed to detect MWCNT in various
Effect of MWCNT on alveolar cell number and on phagocytosis cells Figure 3
Effect of MWCNT on alveolar cell number and on phagocytosis cells. Rats were treated by 1, 10 or 100 μg of CNT. 
After BAL at d1, d7, d30, d90 and d180, total cells were quantified. Results show a significant induction of cells at d7 and d180. 
Results are the mean of ± SD obtained on 6 rats. * Significantly different (p < 0.05) from control group.Particle and Fibre Toxicology 2008, 5:20 http://www.particleandfibretoxicology.com/content/5/1/20
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systemic organs is in favor of elimination rather than a
translocation of MWCNT from the lungs. Nevertheless,
due to the detection limit of our Ni dosage method, a very
limited translocation (< 2% of MWCNT instillated) could
not ruled out. This absence of alveolar passage was also
described in vitro on pulmonary barrier [14]. So, taken
together, all these results show that MWCNT do not seem
to significantly cross alveolar epithelial barrier and that
they are eliminated from the lung. Previous studies on the
elimination of man made mineral fibers (MMVF) showed
a half clearance time near to 4 months [15]. This result
suggests that MWCNT can be eliminated from the lung
with an equivalent time as others fibers in the lung.
The fact that the totality of instilled MWCNT was not
detected at day 1 and day 7, (respectively 63% and 78%)
is probably due to the experimental protocol. Indeed,
MWCNT quantification in the BALF was performed after a
centrifugation troughout a membrane as described in
Materials and Methods section. At this step, free MWCNT
that were present at 1 and 7 days were certainly eliminated
and so was not quantified. This hypothesis is strength-
ened by the fact that difference observed between 1, 7 and
30 days is due to an augmentation of MWCNT in alveolar
cells suggesting a diminution of free MWCNT part in the
lung (Table 1).
Our study of MWCNT localization in the lung showed lit-
tle modification of MWCNT quantity in the parenchyma,
augmentation in alveolar cells (10% at day 1 and 24% at
day 7) and absence in the BALF. In parallel, the observa-
tion of the alveolar cell population by optical microscopy
reveals that the cells were mainly alveolar macrophages
and that there was an increase in the phagocytosing cell
Phagocytosis of MWCNT in vivo Figure 4
Phagocytosis of MWCNT in vivo. After instillation of 2 mg MWCNT, (A) lung and (B) lymph nodes sections were 
observed by TEM and reveal the presence of MWCNT agglomerates in macrophage vesicles. Quantification of (C) EEA1 
mRNA and (D) actin beta mRNA on the lung of rats treated by 1, 10 or 100 μg MWCNT support the MWCNT phagocytosis 
capacity of macrophages. Results are the mean of ± SD obtained on 6 rats. * Significantly different (p < 0.05) from control 
group.
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number well correlated with the chemical dosage of
MWCNT in the cellular part of the BALF. Engulfment of
MWCNT by alveolar macrophages was also confirmed by
TEM observations. This cell localization for MWCNT con-
firms the potential capacity of alveolar macrophages to
phagocyte CNT as it was described before [16,17].
To reinforce that hypothesis, mRNA levels of EEA1 and
beta actin, that are involved respectively in vesicles-endo-
some fusion [13] and in cytoskeleton, were quantified.
50% and 250% induction was observed for respectively
EEA1 and β actin mRNA 1 day after exposure. At high
magnification with TEM, cleaved fragments of MWCNT
were observed in several cells. MWCNT were then
extracted from lung and quantified to avoid quantifica-
tion of tangled MWCNT. This result associated with the
chemical modifications observed by infrared spectroscopy
leads us to hypothesize that alveolar macrophages may
modify the MWCNT they have engulfed, in order to facil-
itate their further elimination from the lung. Nevertheless,
several macrophages that contain MWCNT seemed to be
in apoptosis (figure 7A). This phenomena was previously
described with MWCNT on primary culture of T lym-
phocytes and on T lymphocyte Jurkat cell line [18]. We
have recently shown the capacity of this MWCNT to
induce apoptosis on alveolar macrophages in vivo and in
vitro [19]. The elimination of apoptotic cells needs the
activation of special mechanism requiring the contribu-
tion of Elmo proteins to form a complex with DOCK180
to promote engulfment of apoptotic cells [20]. This elim-
ination was demonstrated to be in pair with the inhibition
of IL10 and GM-CSF protein and absence of inflamma-
tion [21]. We have previously shown that this MWCNT
did not induce inflammation after instillation [19].
Induction of mRNA level of Elmo 1, Elmo 2 and Dock 180
associated with the absence of inflammation and inhibi-
tion of IL10 and GM-CSF protein in the lung of rat expose
by MWCNT is not a proof but is in favor of the presence
of apoptotic cells that are eliminated by phagocytosis.
Thus, we propose the following mechanism as hypothesis
to explain the MWCNT elimination from the lung (see
also figure 9): MWCNT agglomerates may be first
engulfed by alveolar macrophage phagocytosis. After
chemical modification and cleavage of CNT, cells enter in
apoptosis. Then, another macrophages could phagocyte
the apoptotic cells. To eliminate all CNT, these steps could
be repeated as necessary as it is shown on Figure 9.
Conclusion
In summary, we have shown in this work that metallic
impurities of CNT may be used as tracers for CNT pharma-
cokinetics and toxicological studies, insofar as we verified
the impurities-CNT bonds. This approach reveals that the
MWCNT we used don't significantly cross the pulmonary
Effect of MWCNT on alveolar phagocytosis cells Figure 5
Effect of MWCNT on alveolar phagocytosis cells. Rats were treated by 1, 10 or 100 μg of CNT. After BAL at d1, d7, 
d30, d90 and d180, percentage of phagocytosis cells were quantified. Results are the mean of ± SD obtained on 6 rats. * Signif-
icantly different (p < 0.05) from control group.Particle and Fibre Toxicology 2008, 5:20 http://www.particleandfibretoxicology.com/content/5/1/20
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barrier and can be eliminated. This elimination might to
be due in part to macrophages. This hypothesis needs fur-
ther investigations to be confirmed and to reach a better
understanding of the fate of CNT in the body.
Materials and methods
Carbon nanotubes
MWCNT (product number: 636649) was purchased from
Sigma -Aldrich (Lyon, France). These nanotubes were syn-
thesized by Chimical Vapor Deposition method. Their
Physical and chemical modification of MWCNT in vivo Figure 6
Physical and chemical modification of MWCNT in vivo: Physical modifications of MWCNT were observed by TEM on 
(A) control 2 and (B) MWCNT after intratracheal instillation. (C) Length quantification of MWCNT length was performed at 
least on 100 MWCNT per condition (Control1, control 2 and MWCNT after intratracheal instillation. Results are the mean of 
± SD obtained on 3 independent experiment. * Significantly different (p < 0.05) from control group. (D) Chemical modifica-
tions of the MWCNT were assessed by infrared spectroscopy of (a) control 1, (b) control 2 and (c) MWCNT after intratra-
cheal instillation. Spectra of a representative experiment performed on 3 rats.
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diameter ranged from 20 to 50 nm and their length from
0.5 to 2 μm (data from the supplier).
Analysis of MWCNT metal impurities
MWCNT were mineralized in 5 ml nitric acid plus 5 ml
chloridric acid at 180°C for 15 min in a microwave oven
(MarsXpress, CEM, Matthews, NC). The mixture was fil-
trated and the volume was adjusted to 20 ml with distilled
water. Samples were then analyzed for metal content (Li,
Be, B, Na, Mg, Al, Si, S, K, Sc, Ti, V, Cr, Mn, Fe, Co, Ni, Cu,
Zn, Ga, Ge, Se, Br, Rd, Sr, Y, Zr, Nb, Mo, Ru, Rh, Pd, Ag,
Cd, In, Sn, Sb, Te, I, Cs, Ba, La, Ce, Pr, Nd, Sm, Eu, Gd, Tb,
Dy, Ho, Er, Tm, Yb, Lu, Hf, Ta, W, Re, Os, Ir, Pt, Au, hg, Tl,
Pb, Bi, Th and U) by ICP-MS (Elan, 6100DRC, Perkin
Elmer- Sciex).
MWCNT could induce alveolar macrophage (AM) apoptosis and apoptotic cells may be engulfed by other AM Figure 7
MWCNT could induce alveolar macrophage (AM) apoptosis and apoptotic cells may be engulfed by other AM. 
TEM analysis of lung sections of rat instilled with 2 mg of MWCNT showed the presence of apoptotic macrophages. This 
observation is supporting by the quantification of mRNA of (B) Elmo 1, (C) Elmo 2 and (D) Dock 180 suggesting the capacity of 
macrophages to engulf apoptotic cells. Results are the mean of ± SD obtained on 6 rats. * Significantly different (p < 0.05) from 
control group.
A
0
1
2
3
4
5
6
7
1 7 30 90 180
Time (days)
E
l
m
o
 
1
 
m
R
N
A
 
.
Control NT1 NT10 NT100
*
*
* *
B
0
1
2
3
4
5
6
1 7 30 90 180
Time (days)
E
l
m
o
 
2
 
m
R
N
A
 
 
.
Control NT1 NT10 NT100
C *
*
*
0
1
2
3
1 7 30 90 180
Time (days)
D
o
c
k
 
1
8
0
 
m
R
N
A
 
.
Control NT1 NT10 NT100
D
*
* * *Particle and Fibre Toxicology 2008, 5:20 http://www.particleandfibretoxicology.com/content/5/1/20
Page 10 of 13
(page number not for citation purposes)
Preparation of MWCNT suspensions
Different concentrations of MWCNT were suspended in
NaCl in the presence of bovine serum albumin (BSA) at
the same concentration as that of the MWCNT. The sus-
pensions were sonicated 2 mn (5s pause every 10s) at 40
W with an ultrasonic probe (sonicator ultrasonic proces-
sor XL 2020, Misonix incorporated) as previously
described [22]. Using this dispersion method, more than
80% of total agglomerates have a size smaller than 10 μm
and correspond to breathable agglomerates [22].
Animals
Male Sprague-Dawley rats weighing 180–220 g were pur-
chased from Charles River Laboratories (St Germain-sur-
l'Arbresle, France). The rats were kept in a conventional
animal facility and had access ad libitum to food and
drink. The experimental protocol has been approved by
the local ethical committee for animal research.
Transmission Electron Microscopy (TEM) and CNT-Nickel 
bond analysis by Scanning and Energy Dispersive X ray 
microanalysis (STEM-EDX)
2 rats were exposed to NaCl-BSA as control and 6 rats were
exposed to 2 mg of MWCNT by intratracheal instillation.
This high quantity was chosen in order to facilitate the
detection of CNT in the lung for STEM analysis. After 7
days, the animals were anesthetized. The lungs and the
lymph nodes were removed, cut in small sections and
fixed with 2.5% glutaraldehyde. After a postfixation with
1% osmium tetroxide, the samples were dehydrated by
ethanol and embedded in EPON 812 (TAAB). The
ultrathin sections of 90 nm and 150 nm respectively for
TEM and STEM-EDX analysis were obtained by an ultra-
microtome (UCT, Leica), mounted on copper grids and
stained with uranyl acetate and examined in a Tecnai G2
Biotwin (FEI) electron microscope using an accelerating
voltage of 100 kV. Several photographs of entire cells and
of local detailed structures were taken, analysed and com-
pared to NaCl-BSA control samples.
To analyze the bond of CNT and nickel in the body,
STEM-EDX analyses were performed. The organ sections
were prepared as described above for TEM, omitting the
postfixation with osmium tetroxide to avoid an Os peak
in the spectra. Unstained ultrathin sections were analysed
with a dispersive X-ray microanalyser equipped with a
Super Ultra Thin Window (SUTW) model SAPPHIR
(EDAX), at 100 kV.
Intratracheal instillation studies
Rats were intratracheally instillated with 0, 1, 10 or 100 μg
of MWCNT/rat and sacrified 1, 7, 30, 90 and 180 days
later. For each concentration and for each recovery period,
2 groups of 6 rats (group A and group B) were used. Nan-
otube suspensions were prepared as previously described
[22]. Broncho alveolar lavage (BAL) and chemical quanti-
fication of Ni were performed on rats included in the
group A. Histopathology and molecular biology were
assessed on rats included in the group B.
Nickel dosage by Inductively Coupled Plasma -Optical Emission 
Spectrometer (ICP-OES)
Control and exposed animals of group A were anesthe-
tized and the lungs, liver, kidneys, spleen, heart, brain,
lymph nodes, thymus and testis were removed for ICP-
OES nickel assay. The lung was separated in 3 compart-
MWCNT could inhibit the expression of IL10 and GM-CSF protein Figure 8
MWCNT could inhibit the expression of IL10 and GM-CSF protein. Rats were instilled by 100 μg of CNT and quanti-
fication of (A) IL10 and (B) GM-CSF in BALF was performed by ELISA multiplex (Luminex) after 1, 7, 30, 90, 180 days. Results 
are the mean of ± SD obtained on 6 rats. * Significantly different (p < 0.05) from control group.Particle and Fibre Toxicology 2008, 5:20 http://www.particleandfibretoxicology.com/content/5/1/20
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ments: the broncho alveolar lavage fluid (BALF) for detec-
tion of free MWCNT, the cellular part of the BAL for
analysis the part of MWCNT engulfed in cells and the
parenchyma of the lung. The organs were mineralized in
3.5 ml of nitric acid and 1.5 ml of chloridric acid for 4 h
at 100°C and then treated with 1.5 ml of H2O2 for 1 h at
95°C on a heat bloc. The volume was adjusted to 20 ml
with distilled water and samples were analyzed for nickel
content by ICP-OES (Ultima, HORIBA Jobin Yvon, Edi-
son, NJ).
Alveolar cellularity
BAL was performed on anesthetized animals included in
the group A. The lungs were washed 3-times with 9 ml of
phosphate buffered saline (PBS). The BAL was centrifuged
(5 min, 15wa0 g at 4°C) and the cell-free BAL (BALF) was
concentrated using centrifugation (2000 g, 4°C) in Ami-
con Ultra tubes® (Millipore) until the volume was reduced
to 1 ml. The cell number was determined by counting
with a Malassez cell. Differential cell count was performed
on May-Grünwald-Giemsa-stained slides. Specific protein
quantifications were performed in the concentrated BALF
using bio-plex kit for IL10, GM-CSF (Biorad, Cat n°:
171K11070) according to the manufacturer's instructions.
Physical and chemical modification of MWCNT analysis by TEM and 
infrared spectroscopy
A 0.7 mg/ml suspension of MWCNT was produced as pre-
viously described. 150 μl of this suspension was instil-
lated in 3 rats. After 15 days, rats were sacrified by
intraperitoneal injection of pentobarbital and BAL were
performed. A first centrifugation at 350 g for 10 min was
performed to separate the MWCNT and the cells from the
protein fraction. Cells lysis was then done in the presence
Proposition of clearance mechanism of MWCNT in the lung Figure 9
Proposition of clearance mechanism of MWCNT in the lung. MWCNT could be engulfed by macrophages (a), 
hydroxylyzed and cleaved (b). After this step, some cells enter into apoptotic phase (c). Then, a new cell could engulf the apop-
totic macrophages to continue the elimination (d). The last step will be repeated as necessary to eliminate totally the MWCNT 
from the lung (e).
Apoptotic AM 
Alveolar
Macrophage (AM)
MWCNT 
(a) (b)
(c)
(d)
(e)Particle and Fibre Toxicology 2008, 5:20 http://www.particleandfibretoxicology.com/content/5/1/20
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of 300 μl of distillated water. After 1 h, 10 μl of this sus-
pension was loaded on TEM copper grids to measure the
length of MWCNT. In parallel, 2 types of control were
realized. First control was prepared by loading directly 10
μl of the instillated suspension on TEM cooper grid. For
the second control, BAL was performed on untreated rats.
Cells were recovered by a 350 g centrifugation for 10 min.
After removing the protein fraction, cells were lysed in the
presence of water for 1 h and the suspension was put in
presence of 0.7 mg of CNT. After 15 days at 37°C in oven,
the suspension was centrifuged at 350 g for 10 min and
resuspended in water at the same time of MWCNT instil-
lated in rats. 10 μl of this suspension was loading on TEM
cooper grid as control 2.
Treated MWCNT, control 1 and control 2 suspensions
were then centrifuged at 350 g for 10 min. Supernatant
was eliminated by pipeting and put at 37°C over night to
obtain a dry powder. Chemical modification was then
assessed by infrared spectroscopy (Nicolet 510M) on 70
μg of commercial MWCNT powder, control 1 powder,
control 2 powder and treated MWCNT in the presence of
260 μg of KBr.
Phagocytosis makers' by reverse transcription real time polymerase 
chain reaction (RT-qPCR)
30 mg of lungs from group B rats was disrupted using Pre-
cellys® 24 lysis/homogenizer (Bertin technologies, France)
and total RNA was extracted with RNeasy® plus Mini Kit
according to manufacturer's protocol in presence of 600
μl of RLT buffer. 1 μg of total RNA was reverse transcribed
to cDNA with Omniscript® Reverse Transcription kit (Qia-
gen, France) according to the manufacture's protocol
using OligodT primer (Qiagen).
The quantification of mRNA for RPL32 (first housekeep-
ing gene, Cat n° QT00444857), GNB2L1 (second house-
keeping gene, Cat n° QT00193872), EEA1 (Cat n°
QT01619121), β actin (Cat n° QT00193473), Elmo 1
(Cat n° QT01581930), Elmo 2 (Cat n° QT00365680),
Elmo 3 (Cat n° QT00382214) and Dock 180 (Cat n°
QT01684081), transcript were performed using Quanti-
Tect™ Primer®  Assay (Qiagen) and QuantiTect™ Sybr
Green® Kit (Qiagen) according to the manufacturer's pro-
tocols on 100 ng of cDNA using Mastercycler® ep realplex
4 S (eppendorf, France). Each sample was run in triplicate.
Statistics
All data were expressed as mean ± S.D (standard devia-
tion). Differences between groups were assessed by the
one-way analysis of variance (ANOVA). If the variances
between groups were homogenous, groups were subjected
to the multiple comparison Dunnett's test. If the variances
were not homogeneous, groups were compared by the
Mann-Whitney test. *P < 0.05 was considered as the sta-
tistical significance level.
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